Publications by authors named "Taryn Sisserson"
Arch Pathol Lab Med
November 2024
Article Synopsis
- The study focuses on the VENTANA FOLR1 Assay, which detects the overexpression of folate receptor-α (FRα) in epithelial ovarian cancer, a key biomarker for targeted therapy.
- The assay demonstrates high reliability, with over 98% agreement in repeatability and a 98.4% staining acceptability rate during the SORAYA clinical trial, indicating its effectiveness in selecting patients for treatment.
- Findings show that the VENTANA FOLR1 Assay is a robust tool for identifying ovarian cancer patients who may benefit from treatment with mirvetuximab soravtansine (MIRV).
